£11.64m
−2%vs Mar 2024From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Amarox Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Amarox Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AMAROX LIMITED is an active private limited company (company number 10997632) incorporated on 5 October 2017, registered in Harrow. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest group accounts cover the period ending 31 March 2025, showing net assets of £11.64m and cash of £93k. Net assets fell 2% on the prior period (£11.85m).
Peer position · net assets
By net assets it sits in the top quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Ownership and control
- Hetero Fzco
- owns 75–100% of shares
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 5 October 20179 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 19 October 2027in 360 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 68100
- Buying and selling of own real estate
- Accounts type
- Group
- Size band
- MicroCompanies Act thresholds
05
Financials
£93k
−32%vs Mar 2024Not reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £11.64m | £93k | — | £42.85m | — | −£829k | — |
| 31 March 2024 | £11.85m | £138k | — | £29.11m | — | −£1.85m | — |
| 31 March 2023 | — | — | — | — | — | — | — |
Current ratio0.62Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £11,640,720 at 31 March 2025
- Current assets below creditors within one yearCurrent ratio 0.62
- Cash at bank of £50,000 or moreCash £93,018
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 5 October 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 360 days
- Next accounts duein 68 days
- Accounts period endNet assets £11.64m · group accounts
- Accounts period endNet assets £11.85m · group accounts
- Accounts period end
- Incorporated
08
Similar companies in Greater London
- MARIGOLD PROJECTS JAMAICA LIMITEDEnfield · inc. Aug 2017
- PAVAY VENTURE INTERNATIONAL LIMITEDWembley · inc. Jan 2018
- ALPS BIOSCIENCES LIMITEDHounslow · inc. May 2017
- ADVANCED RETENTION THERAPEUTICS & RESEARCH LTDGreenhithe · inc. Feb 2017
- SHAMA PHARMA LTDGreenford · inc. Jan 2017
- ALPHACELLS BIOTECHNOLOGIES LIMITEDSutton · inc. Feb 2019
All companies incorporated on 5 October 2017 · in Oct 2017.
09
Reminders for AMAROX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.